• Leuko is a startup spun out from MIT and the Madrid M+Vision Consortium. They are developing a platform technology to noninvasively measure blood parameters. The scalable PointCheck™ solution combines optics and AI to make blood testing easier, faster, more accessible, and cost-effective than the state-of-the art solutions. In 2017, Carlos Castro-Gonzalez, Aurelien Bourquard, Ian Butterworth and Alvaro Sanchez-Ferro co-founded Leuko. Together they co-invented Leuko’s proprietary PointCheck™ technology for non-invasive white blood cell monitoring. https://leuko.io/

Leuko Labs was our 2018 #StartupWorldCup Grand Finale Champion who have announced yesterday that they have raised $1.8 million seed round. Leuko Labs is a MIT-born technology startup developing the first non-invasive white blood cell monitoring device.

They raised $1.8 million in seed financing from Pegasus Tech Ventures, Good Growth Capital, Nina Capital, and others.

Founded by four MIT scientists and entrepreneurs, two of whom are also alumni of Universidad Politécnica de Madrid, Leuko is  developing PointCheck™, the company’s proprietary device to measure white blood cell levels non-invasively, which can enable improved clinical outcomes and reduced costs for immunosuppressed patients. The device takes its measurements from a patient’s finger without drawing blood.


Patients need a way to monitor how they are reacting to treatments, daily and non-invasively from the comfort of their homes, and physicians need this insight to more precisely adjust treatments. If physicians are alerted when a patient's white blood cells drop to dangerously-low levels, preventive treatment could be deployed to avoid life-threatening infections, improve clinical outcomes, and reduce hospitalization costs. “Our vision is that patients will have a PointCheck™ portable device that they can take home to do just that,” said Carlos Castro-Gonzalez, Leuko’s CEO and co-founder. "The new investment supports ongoing development and clinical studies of our platform technology, to ultimately turn this vision into reality.”

Good Growth Capital (GGC), a venture capital fund based between Boston and Charleston and focused on early stage technology companies, has led the investment.

“In the short time since GGC’s first investment, Leuko has made significant progress in developing a platform that is demonstrably faster, more efficient and more scalable than traditional methods,” said Amy Salzhauer, managing partner at GGC. “We’re excited to invest in Leuko and help accelerate their path to market as they aim to transform the care of immunosuppressed patients by dramatically improving the efficiency of cell testing.”



  • Founded in 2013 in Japan, UniFa develops an IoT solution for tracking kindergarteners' physical and mental growth
  • Launched new service "Look-me nap check," which offers a simple button from the sensor to support safety and security of children by monitoring children's sleep
  • $10M funding after they became the Startup World Cup 2017 champion
  • 8 famous Japanese venture funds and corporations
  • 6x increase in sales

  • 3x increase in customer 

  • 2x increase in employees

  • Partnership with Toppan Printing, Froebel-Kan, and more

  • Expected IPO in 2020 

*Disclaimer: The above information is presented for illustrative purposes only. UniFA is not a portfolio holding of SWC Fund. This presentation is not intended as a recommendation to purchase or sell any security.  Past performance of these strategies is not necessarily indicative of future results. Pegasus Tech Ventures makes no implications, warranties, promises, suggestions or guarantees whatsoever, in whole or in part, that by participating in any investment of or with Pegasus Tech Ventures you will experience similar investment results. There is the possibility of loss and all investment involves risks including the loss of principal.  This presentation was prepared by Pegasus Tech Ventures and is believed by the Pegasus Tech Ventures to be reliable and has been obtained from public sources believed to be reliable. Pegasus Tech Ventures makes no representation as to the accuracy or completeness of such information. 

SWC Logo - White Text.png